ASCO® GI 2024 Insights: "Clinical Validation of Northstar Response, a Novel Methylated ctDNA Therapy Response Monitoring Assay in Patients With Advanced GI Cancer Undergoing Active Treatment"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

ASCO® GI 2024 Insights: "Clinical Validation of Northstar Response, a Novel Methylated ctDNA Therapy Response Monitoring Assay in Patients With Advanced GI Cancer Undergoing Active Treatment"

By Insights from 2024 ASCO® GI Annual Meeting FEATURING Ilyas Sahin

49 views

February 5, 2024

0 Comments

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Safety and Efficacy Data of a TKI Monotherapy in HCC

Feat. J. Mizrahi

Early-Onset CRC: A New Epidemic With Knowns and Unknowns

39:40

Ibrahim Sahin

Young Onset Colorectal Cancer: A New Epidemic?

48:38

UNC Lineberger Comprehensive Cancer Center

Cancer Screening in Primary Care: An Evidence-Based Review of Outpat…

Feat. N. Robertson

46:37

Albert Einstein College of Medicine

Screening for Pancreatic Cancer

Feat. A. L. Lucas

19:39

Vanderbilt University Medical Center (VUMC)

Helicobacter Pylori: A Bacterium That Causes Gastric Cancer

Feat. R. Peek

19:48

Florida Gastroenterologic Society

Colon Polyp with Carcinoma In-Situ, Intramucosal Cancer or Invasive …

Feat. D. Yang

53:40

Philadelphia County Medical Society

Current Status for the Early Detection of Pancreatic Cancer

Feat. R. Brand

26:18

Scripps MD Anderson Cancer Center

Updates in Current CRC Screening Guidelines

Feat. J. Willis

21:24

Icahn School of Medicine at Mount Sinai

Mount Sinai School of Medicine Colon Cancer Screening Updates

Feat. C. Cao

13:43

MedNews Week

Factors Driving Young Onset Colorectal Cancer

Feat. A. Khorana

28:25

Integrity Continuing Education

Extensive, Liver-Only Metastases From Colon Cancer: Case Presentatio…

Feat. V. Lee, E. Christenson, N. Bhagat, E. Winslow

19:57

Yale Cancer Center

Yale Cancer Center Updates on CRC Screening

Feat. S. Bogardus

22:33

Integrity Continuing Education

Oligometastatic Colon Cancer to Liver: Case Presentation and Panel D…

Feat. V. Lee, R. Kumar, N. Bhagat, E. Winslow

17:54

Houston Methodist Hospital

AI in GI: Colon Cancer Screening and Beyond

Feat. R. Schiesser

24:19

Total Health

Tackling Early Onset Colorectal Cancer

Feat. S. Kim

26:48

Integrity Continuing Education

Locally Advanced High-Rectal Cancer: Case Presentation and Expert Pa…

Feat. V. Lee, R. Kumar, A. Gabre-Kidan, E. Christenson

09:03

Integrity Continuing Education

Combined Hepatocellular-Cholangiocarcinoma: Diagnosis and Management

Feat. J. Birkness-Gartman

67:58

Scripps Health

Advances in Hepatocellular Carcinoma Diagnosis and Treatment

Feat. A. Singal

47:17

Scripps Health

Update on GI Cancers: Focus on Prevention and Screening

Feat. W. Coyle

34:13

The University of Kansas Cancer Center

ctDNA Applications in Colorectal Cancer

Feat. A. Dasari

Login

Login

Join VuMedi

ASCO® GI 2024 Insights: "Clinical Validation of Northstar Response, a Novel Methylated ctDNA Therapy Response Monitoring Assay in Patients With Advanced GI Cancer Undergoing Active Treatment"

Related Content